A case of interstitial pneumonia during gemcitabine and cisplatin chemotherapy for locally advanced bladder cancer

Acta Urologica Japonica

Volumn 57, Issue 2, 2011, Pages 81-85

  Matsumura, Eiri ^a   Ashikari, Asuka ^a   Tasaki, Shinsuke ^a   Haranaga, Syusaku ^a   Toyosato, Tomotsune ^a   Ashimine, Satoshi ^a   Machida, Noriko ^a   Oshiro, Yoshinori ^a   Saito, Seiichi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Drug induced interstitial pneumonia; Gemcitabine

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

AGED; ARTICLE; BLADDER TUMOR; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; URINARY BLADDER NEOPLASMS;

EID: 79953157687     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. von der Maase H, Hassen SW, Roberts JT, et al.: Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cislatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicentcr, phase III study. J Clin Oncol 31: 7-12, 2000
2. Okada S, Ueno H, Okusaka T, et al. : Phase I trial of gemcitabine in patients with advanced pancreatic cancer. Jpn J Clin Oncol 31: 7-12, 2001 (Pubitemid 32236880)
3. LY188011 Gemcitabine 23: 1681-1688, 1996
4. Shaib W, Lansigan F, Cornfeld D, et al.: Gemcitabineinduced pulmonary toxicity during adjuvant therapy in patient with pancreatic cancer. JOP 9: 708-714, 2008
5. Barlesi F, Vallani P, Doddoli C, et al.: Gemcitabineinduced severe pulumonary toxicity. Fundam Clin Pharmacol18: 85-91, 2004
6. Gemcitabine 72 : 84-88. 2010
7. Linskens RK, Goldig RP, Groeningen CJ, et al.: Severe acute lung injury induced by gemcitabine. Neth J Med 56: 232-235, 2000 (Pubitemid 30255947)
8. Kudoh S, Kato H, Nishiwaki Y, et al.: Intersititial lung disease in Japancase patients with lung cancer: a cohort and nested case-control study. AmJ Respir Crit Care Med 177: 1328-1357, 2008
9. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Resp Crit Care Med 165: 277-304, 2002
10. Gotway MB, Freemer MM and King TE Jr: Challenges in pulmonary fibrosis. 1 : use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias. Thorax62: 546-553, 2007
11. Ohnishi H, Yokoyama A, Kondo K, et al.: Comparatine study of KL-6, surfactant protcin-A, surfactant protein-D, and monocyte chcmoattractant protein-1 as scrum markers for interstitial lung disease. Am J Resp Crit Care Med 165: 378-381, 2002